Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)

CAPS Rating: 2 out of 5

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.

Recs

0
Player Avatar polvo23 (< 20) Submitted: 2/11/2007 7:51:58 PM : Outperform Start Price: $3.31 THLD Score: +108.03

phase 3...did all the research

Featured Broker Partners


Advertisement